Department of Anesthesiology, Critical Care and Pain Medicine, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
Inflammation. 2018 Aug;41(4):1297-1303. doi: 10.1007/s10753-018-0778-7.
Saikosaponin a (SSa), a triterpenoid saponin, has numerous pharmacological properties, including anti-inflammatory and antioxidant effects. The purpose of this study was to investigate whether and how SSa protected against cigarette smoke (CS)-induced lung inflammation in mice. The mice were exposed to CS and SSa was administered by an intraperitoneal (i.p.) injection 1 h before CS treatment for 5 consecutive days. The results showed that SSa significantly inhibited CS-induced inflammatory cell infiltration, NO, TNF-α, and IL-1β production in BALF. SSa also inhibited CS-induced MPO and MDA contents in lung tissues. Furthermore, SSa significantly inhibited CS-induced NF-κB and upregulated the expression of Nrf2 and HO-1. In conclusion, these results support a therapeutic potential for SSa in CS-induced lung inflammation.
柴胡皂苷 a(SSa)是一种三萜皂苷,具有多种药理作用,包括抗炎和抗氧化作用。本研究旨在探讨 SSa 是否以及如何防止香烟烟雾(CS)诱导的小鼠肺炎症。小鼠暴露于 CS 中,SSa 通过腹腔(i.p.)注射在 CS 处理前 1 小时给药,连续 5 天。结果表明,SSa 显著抑制 CS 诱导的炎症细胞浸润、BALF 中的 NO、TNF-α 和 IL-1β 的产生。SSa 还抑制 CS 诱导的肺组织中 MPO 和 MDA 含量。此外,SSa 显著抑制 CS 诱导的 NF-κB,并上调 Nrf2 和 HO-1 的表达。总之,这些结果支持 SSa 在 CS 诱导的肺炎症中的治疗潜力。